A review of our peer-reviewed research in the healthcare and mainstream press.
The Patient Engagement HIT website featured an article on a recent American Journal of Managed Care (AJMC) study, “Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation.” It discussed the study’s argument that healthcare industry stakeholders and CMS should consider modifications to the patient engagement requirements as the optional reporting period for Stage 3 Meaningful Use approaches.
Care of Adults with Chronic Childhood Conditions, a guidebook published by Springer, cited an AJMC study in the chapter “Adherence and Self-Management.” The cited study discussed how text messaging could be used for chronic disease management.
MedPage Today published a compilation of cardiology news items that included an article from AJMC’s coverage of the 2016 meeting of the American College of Rheumatology. The article discussed a new study presented at the meeting suggesting that “a test used to predict future disease activity in patients with rheumatoid arthritis (RA) might someday tell physicians which patients are at risk for cardiovascular events, such as heart attacks or coronary infection.”
An article in BMC Public Health, “Healthy and Productive Workers: Using Intervention Mapping to Design a Workplace Health Promotion and Wellness Program to Improve Presenteeism,” referenced an AJMC study. That study, “A Systematic Review of Measurement Properties of Instruments Assessing Presenteeism,” examined the relative value of instruments that measure presenteeism (decreased productivity while at work).
Study Highlights BMP7 As a Potential Therapeutic Target for Ovarian Cancer
November 30th 2023High Bone Morphogenetic Protein 7 (BMP7) expression was significantly associated with aggressive phenotypes, including advanced grade, International Federation of Gynecology and Obstetrics stage, residual disease, and adverse overall survival.
Read More
7-Day Dosing of Azacytidine Shows Benefit for Females With High-Risk MDS Not Seen in Males
November 30th 2023Investigators from several medical centers in Japan were surprised to find that women with myelodysplastic syndrome (MDS) had a survival advantage from a 7-day dosing schedule, but that benefit compared with a reduced schedule was not seen in men.
Read More
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More